Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 1 Patients with SARS-CoV-2 associated polyradiculitis as reported by the end of December 2020

From: Guillain-Barre syndrome in 220 patients with COVID-19

Age (years) Sex Onset LOO (days) Subtype CIC CM IVIG AV Recovery Country
61 f B 9 AIDP nr No Yes No Yes China
65 m A 9 AMSAN nd DM Yes No nr Iran
54 m A 8 AIDP nr No Yes Yes Yes USA
70 f A 23 AIDP nd No Yes Yes nr Italy
66 f A 7 AIDP No nr Yes Yes Yes Italy
54 f A 21 AIDP nd No Yes No Yes Germany
70 f A 3 AMSAN No RA Yes No Partial Morocco
20 m A 5 AMAN nd No Yes No Yes India
71 m A 4 AIDP No AHT, AAR, LC Yes Yes Death Italy
64 m A 11 AIDP nd No Yes Yes nr France
nr nr A 7 AIDP No nr Yes No Partial Italy
nr nr A 10 AIDP No nr Yes No Yes Italy
nr nr A 10 AMAN No nr Yes Yes Partial Italy
nr nr A 5 AMAN No nr Yes No Partial Italy
nr nr A 7 AMAN No nr Yes, PE No nr Italy
50 m A 3 MFS, PNC No No Yes No Yes Spain
39 m A 3 MFS, PNC No No No No Yes Spain
61 m A 10 MFS No No S No Yes Spain
76 f A 8 GBS (no NCS) nd No No nr Death Spain
~ 75 m B 10 AIDP No No Yes No Yes Swiss
43 m A 10 AIDP nr nr Yes No Yes Spain
64 m A 23 AIDP No nr Yes No Yes France
72 m A 7 AIDP No AHT, CHD, AL Yes Yes Partial USA
~ 65 m A 17 AIDP No No Yes No Yes Italy
67 f A 10 nr No Breast cancer PE Yes Partial USA
54 m A 14 AIDP nd nr Yes No Partial USA
43 m A 21 AIDP No nr Yes No Yes France
71 f A 10 AIDP No nr Yes No Partial France
36 m A 4 MFS nr nr Yes No Yes USA
55 m A 20 AIDP No nr Yes Yes Partial Italy
60 m A 3 AMSAN No nr Yes Yes Partial Italy
58 m AB 0 AIDP No No Yes No Partial Canada
52 f A 15 AIDP No nr Yes No Partial Swiss
63 f A 7 AIDP nr nr Yes No Yes Swiss
61 f A 22 AIDP No nr Yes No Partial Swiss
53 f B nr AIDP No No PE No Partial Turkey
51 f A 14 MFS nr nr Yes No Partial Spain
56 f A 15 AIDP No nr Yes Yes Partial Spain
68 m A 14 AIDP nr (ASPC) nr Yes, PE Yes Partial Austria
55 f A 14 AIDP nr No Yes Yes Partial Spain
53 m A 24 AIDP No No Yes No Yes Netherlands
57 m A 6 AIDP No AHT, psoriasis Yes Yes Partial UK
21 m A 16 AIDP nr AHT, DM PE No Yes USA
41 m A 10 AIDP nr DM Yes No Partial Iran
38 m A 16 AIDP nr AHT PE No Yes Iran
14 f A nr GBS nr No Yes No Yes Iran
49 m A 14 AIDP No No Yes No Yes UK
68 m A 5 AIDP nr AHT, HLP Yes No Yes Italy
11 m A 21 AIDP nr No Yes No Yes Saudi
15 m A nr AMAN No No Yes No Partial Brazil
72 m A 18 AIDP No nr Yes Yes Partial Italy
72 m A 30 AIDP No nr Yes Yes Partial Italy
49 f A 14 AIDP No nr Yes No Partial Italy
94 m A 33 AIDP nr nr S No Partial Italy
76 m A 22 AIDP No nr Yes Yes Partial Italy
64 m A nr GBS? nr DM Yes Yes Yes Japan
77 m A nr AIDP nr AHT, HLP Yes No Yes Spain
58 f A 6 AIDP No nr PE No Yes USA
56 f A 7 AIDP No AHT, thyroxin ↓ nr nr Partial Germany
61 f A 14 AMAN No AHT, HLP PE No Yes USA
75 m A nr nr No spinal trauma Yes No Yes USA
37 nr A 10 nr nr nr nr nr nr Belgium
60 f A 22 nr nr Migraine Yes No Partial USA
∅57 33 m nr 0–37 nr nr nr Yes, n = 46 nr Death, n = 1 UK, n = 47
        PE, n = 1   nr, n = 46  
51 m A 12 AIDP No nr Yes Yes Partial Germany
34 m A 4 PNC nr Strabism Yes No Partial USA
71 f A Days PNC nr AHT No No Partial USA
65 m A 3 AIDP nr No Yes No Yes Germany
74 f A nr AIDP No Lymphoma Yes No Yes Spain
49 m A 14 MFS No Crohn’s disease Yes Yes partial USA
65 f A nr AIDP nr Fibromyalgia Yes Yes Death Italy
12 m A 7 nr nr No Yes Yes Death Tanzania
88 f A 2 AMSAN nr nr PE Yes Partial Iran
47 m A 7 AMSAN nr nr PE Yes Death Iran
58 m A 9 AMSAN nr nr Yes, PE Yes Death Iran
54 m A 3 nr nr GBS, DN Yes No Yes USA
57 m A nr AMAN nr nr Yes No nr Italy
37 m A 14 AIDP nr nr Yes Yes Partial Iran
41 m A 10 AIDP No nr Yes No Yes Guinea
76 m A 7 AIDP No Cardiomyopathy Yes No Partial France
∅59.2 22 m A 16–35 AIDP, n = 23 nr Several n = 25 n = 5 Partial UK, n = 30
     AMAN, n = 2    PE, n = 2    
44 m A nr nr nr AHT, asthma Yes No Yes USA
54 f A 20 AMAN nr Asthma No No Partial Japan
55 f A 11 AMSAN nr Lung disease Yes Yes Death Iran
8 m B nr AIDP No No Yes Yes Partial USA
65 m A 14 AIDP nr nr Yes No Partial Iran
70 f A 90 nr nr RSD Yes No Yes USA
55 f A 10 AMAN nr DM, AHT Yes No Partial India
72 m A 6 AIDP nr AHT Yes Yes Death India
55 m A 7 AMSAN nr DM, AHT, RI Yes No Partial India
49 m A 10 AIDP nr DM, AHT Yes No Partial India
53 m A nr nr nr nr Yes No Partial Italy
36 m A 18 AIDP nr AHT, NTX Yes Yes Partial USA
57 m A 17 AIDP nr nr Yes No Partial Italy
∅53 11 m A 0.5–28 AIDP No, n = 4 nr Yes, n = 15 nr Partial, Italy, n = 17
        PE, n = 2   Death, n = 1  
54 f AB 0 nr No AHT Yes No Partial Spain
58 f A 14 nr nr Disc prolapse Yes No Partial USA
65 m A nr AIDP nr nr Yes No Partial Italy
73 m AB 0 AIDP No nr Yes No Partial Italy
55 m A 20 AIDP/MFS No nr Yes No Partial Italy
46 f A 3 AIDP No nr Yes No Partial Italy
60 m A 20 AMSAN No nr Yes No Partial Italy
63 f A 15 AMSAN nr nr Yes No Partial Italy
~ 35 m A nr AMAN No nr Yes No Partial UK
49 m A 11 PCB No AHT, seminoma No No Partial Italy
54 m A 4 AIDP nr AHT, obesity Yes Yes Partial Spain
54 nr nr nr nr No AHT, HLP Yes Yes Yes Spain
72 f A 8 AIDP No nr Yes Yes Partial Italy
48 m A 18 AIDP nr DM PE No Partial USA
46 m A 18 AIDP nr nr No No Partial Iran
65 m A 10 AIDP nr nr Yes No Partial Iran
66 f B No symptom AIDP nr nr Yes No Partial Italy
66 f A 30 AIDP nr DM, AHT, arthritis Yes No Partial Iran
55 f A 31 AMSAN nr COPD Yes Yes Death Iran
14 f A nr nr nr No Yes No Yes Iran
38 m A 16 AIDP nr No PE No Partial Iran
20-63 7 m nr nr AIDP nr nr Yes No Partial UK, n = 7
65 m A 5 AIDP nr DM, AHT Yes Yes Death Sudan
43 m A 10 AIDP nr nr Yes No Partial Spain
63 m A 1 MFS nr nr No No Partial UK
61 m A nr MFS No nr Yes No Yes Germany
58 m B nr AIDP nr nr Yes Yes Partial UK
70 f A 15 AMAN nr AHTt, obesity Yes, PE No Partial Italy
  1. A, onset of GBS after onset of non-neurological manifestations; AAR Aortic aneurysm repair; AHT Arterial hypertension; AL Alcoholism, ASPC Antibodies for SARS-CoV-2 positive in CSF; AV Artificial ventilation; B, onset of GBS before onset of non-neurological manifestations; CHD Coronary heart disease; CIC CoV2 in CSF; CM Comorbidities; DM Diabetes; f Female; HLP Hyperlipidaemia; LC Lung cancer; LOO Latency between onset of GBS and COVID-19 respectively vice versa; m Male; nd Not done; nr Not reported; NCS Nerve conduction study; NTX Renal transplantation; pc Personal communication; PCB Pharyngeal, cervical, brachial variant of GBS; PE Plasma exchange; PNC Polyneuritis cranialis; RA Rheumatoid arthritis; RI Renal insufficiency; RSD Reflex sympathetic dystrophy; S Steroids
Back to article page